Targeting the HER family with Pan-HER effectively overcomes resistance to cetuximab

Cetuximab, an antibody against the Epidermal Growth Factor Receptor (EGFR) has shown efficacy in treating head and neck squamous cell carcinoma (HNSCC), metastatic colorectal cancer and non-small cell lung cancer (NSCLC). Despite the clinical success of cetuximab, many patients do not respond to cet...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mol Cancer Ther
Главные авторы: Iida, Mari, Bahrar, Harsh, Brand, Toni M, Pearson, Hannah E, Coan, John P, Orbuch, Rachel A, Flanigan, Bailey G, Swick, Adam D, Prabakaran, Prashanth, Lantto, Johan, Horak, Ivan D., Kragh, Michael, Salgia, Ravi, Kimple, Randy J, Wheeler, Deric L
Формат: Artigo
Язык:Inglês
Опубликовано: 2016
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5010956/
https://ncbi.nlm.nih.gov/pubmed/27422810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-16-0012
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы